Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

Swissmedic approves the use of the monoclonal antibody cocktail Ronapreve developed by Roche and Regeneron to treat severe COVID-19 patients

Swissmedic approves the use of the monoclonal antibody cocktail Ronapreve developed by Roche and Regeneron to treat severe COVID-19 patients.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthSwissmedic approves the use of the monoclonal antibody cocktail Ronapreve developed by Roche and Regeneron to treat severe COVID-19 patients

Swissmedic approves the use of the monoclonal antibody cocktail Ronapreve developed by Roche and Regeneron to treat severe COVID-19 patients.

View Premium plansBrowse free archive reports